Regulatory News
Tuesday, November 22, 2016
U.S. FDA lifts hold on AstraZeneca head and neck cancer trials
LONDON, Nov 22 (Reuters) - U.S. officials have given a green
light for two clinical trials testing AstraZeneca's
cancer immunotherapy drug durvalumab in head and neck cancer to
resume recruiting...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment